ESMO - Eur. Oncology
@myESMO
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
ID:69232855
http://www.esmo.org 27-08-2009 07:45:16
17,4K Tweets
75,0K Followers
874 Following
Follow People
Antibody–drug conjugates are active in patients with HER2+ breast cancer brain metastases: where do we go from here? Read the editorial on the brain mets analysis from DB03 by Sarah Sammons (Dr Sarah Sammons) and Nancy Lin (@nlinmd) from Dana-Farber’s Breast Oncology Center. esmoopen.com/article/S2059-…
ESMO welcomes the adoption of the #EHDS in the European Parliament plenary today, reflecting key provisions to support #CancerResearch advocated for by the Society.
To learn more, read the news esmo.org/policy/policy-…
I believe that such an updatable tool provides crucial support for optimal #TreatmentDecisionMaking in pts with non-oncogene addicted metastatic #NSCLC and PDL1 over 50%, plus #brainmets . #IAmAPractisingOncologist & I use #ESMOLivingGuidelines . @myesmo RADU VIDRA Mila Petrova
Very interesting #ESMOYOC #YO4YO session later today…looking forward to seeing you online !!!
ESMO - Eur. Oncology OncoAlert Maria Kfoury Véronique Debien Joseph Ciccolini Università di Genova Ospedale San Martino Genova francescalongo Evandro de Azambuja, MD, PhD Andres Cervantes
➡️Today - Learn how standardised primary data can improve patient outcomes and real-world evidence research. Register now for this #DigitalOncology webinar: 🔗ow.ly/P4vU50RjSTY
Tomorrow, do not miss the chance to follow Véronique Debien, Joseph Ciccolini and Maria Kfoury
to learn how to optimize drug dosing and interpreting PK/PD results.
📅 23 April, 18:00-19:00 CEST
ow.ly/6Tae50Rlb8S
📣📣📣 Dear colleagues & ESMO - Eur. Oncology members, please help us to understand more about current role & future potential of #DigitalHealth technology in #oncology 💻
📋Link to our #ESMOYOC survey:
esmo.eu.qualtrics.com/jfe/form/SV_4V…
Matteo Lambertini, MD PhD Andres Cervantes Evandro de Azambuja, MD, PhD francescalongo
➡️Exciting news: Registration for #ESMOAsia24 is now OPEN. Join us in Singapore for an enriching experience in oncology, presenting clinical trials from Asia-Pacific & beyond.
Take advantage of early registration rates & secure yr seat today: 🔗ow.ly/90RO50Rj2gL
Just wrapped up 📢 An exceptional #ESMOAdvancedCourse in Hong Kong, exploring 'Perioperative Strategies in Localised Malignancies: Advancements & Future Prospects in #LungCancer .' More here 🔗ow.ly/esfR50RkRAn
Upcoming Courses 👉ow.ly/5F2s50RkRAc
Tony Mok @quantumonc
👉The last webinar in the #PrecisionOncology series is now available to the entire oncology community.
Access with your ESMO account: 🔗ow.ly/QbL750Rj8oz
Claudia Cardone Vivek Subbiah, MD Sewanti Limaye 🇮🇳🇺🇸 Ben Westphalen George Pentheroudakis
➡️Make the most of your ESMO membership: register now to deepen your knowledge on #BreastCancer and have your questions answered by world-renowned leaders in the field in this real-time discussion.
Register now:🔗ow.ly/BxsK50Rj0iZ
➡️Secure your place now to stay up-to-date with the ongoing European efforts in digital health interoperability for an optimal clinical data exchange. Register now for this #DigitalOncology webinar: 🔗ow.ly/IzCW50Rj5tX
Learn best practice recommendations for the prevention, treatment and management of this condition affecting an increasing number of individuals with cancer. #ESMOGuidelines
Christina Ruhlmann Pablo Mando Alice Indini
🔗 ow.ly/jbHn50Rg5LE